Issue of equity

Application has been made to AIM for the admission of 12,000 new ordinary shares of 1 pence each in the Company to trading (the “New Shares”). The New Shares, which will rank pari passu in all respects with the Company’s existing shares in issue, have been allotted pursuant to the exercise of options by an employee of the Company. Admission of the New Shares is expected to become effective on 30 December 2014.

Following the issue of the New Shares the total number of ordinary shares of 1 pence each (“Ordinary Shares”) in the Company with voting rights will be 20,136,300. The Company does not hold any Ordinary Shares in Treasury.

The above figure of 20,136,300 Ordinary Shares may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the Financial Conduct Authority’s Disclosure and Transparency Rules.


Stuart Gall CEO, MedaPhor Group plc. Tel: +44 (0)2920 756534

Bobbie Hilliam, Nominated Advisor, Cenkos Tel: +44 (0)207 3978900

Julian Morse, Corporate Broking, Cenkos Tel: +44 (0)207 3978900